price
NASDAQ · AURA
Aura Biosciences, Inc.
Healthcare · Biotechnology
$6.56
Up+$0.22 (+3.47%)
Updated Nov 8, 2026, 11:20 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 413.26M
- P/E ratio
- -3.72
- Dividend yield
- 0.00%
- 52-week range
- $5.31 – $9.54
- Volume
- 859.02K
- Avg. volume
- 260.47K
Price performance · AURA
AURA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
AURA closed at $6.56 after 20 trading sessions, up 0.31% for the selected period.
- Last close
- $6.56
- Period change
- +0.31%
- Period low
- $6.03
- Period high
- $6.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $6.35 | $6.66 | $6.17 | $6.56 | 859.02K |
| Nov 5, 2026 | $6.55 | $6.63 | $6.27 | $6.34 | 790.87K |
| Nov 4, 2026 | $6.42 | $6.66 | $6.255 | $6.65 | 1M |
| Nov 3, 2026 | $6.07 | $6.325 | $6.045 | $6.24 | 643.08K |
| Nov 2, 2026 | $6.13 | $6.16 | $5.88 | $6.03 | 746.58K |
| Oct 30, 2026 | $6.30 | $6.43 | $6.03 | $6.14 | 533.01K |
| Oct 29, 2026 | $6.46 | $6.51 | $6.26 | $6.295 | 769.98K |
| Oct 28, 2026 | $6.27 | $6.41 | $6.21 | $6.40 | 541.88K |
| Oct 27, 2026 | $6.20 | $6.31 | $6.095 | $6.30 | 680.26K |
| Oct 26, 2026 | $6.31 | $6.42 | $6.145 | $6.18 | 907.59K |
| Oct 23, 2026 | $6.33 | $6.40 | $6.16 | $6.30 | 722.14K |
| Oct 22, 2026 | $6.46 | $6.59 | $6.35 | $6.46 | 955.32K |
| Oct 21, 2026 | $6.46 | $6.61 | $6.385 | $6.46 | 933.6K |
| Oct 20, 2026 | $6.32 | $6.77 | $6.18 | $6.56 | 1.16M |
| Oct 19, 2026 | $6.13 | $6.37 | $6.12 | $6.29 | 556.79K |
| Oct 16, 2026 | $6.31 | $6.355 | $6.095 | $6.10 | 762.49K |
| Oct 15, 2026 | $6.23 | $6.415 | $6.17 | $6.34 | 604.52K |
| Oct 14, 2026 | $6.21 | $6.28 | $6.085 | $6.17 | 1.01M |
| Oct 13, 2026 | $6.53 | $6.56 | $6.18 | $6.27 | 1.66M |
| Oct 12, 2026 | $6.55 | $6.70 | $6.50 | $6.54 | 613.14K |
Latest AURA news
The latest Smart Investors Daily articles mentioning AURA.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…